QRX 0.00% 2.8¢ qrxpharma ltd

I listened to the telephone conference - I must say a very...

  1. 924 Posts.
    lightbulb Created with Sketch. 20
    I listened to the telephone conference - I must say a very impressive deal with a very impressive strategic partner. This has massive upside growth potential with only US market covered at this stage.

    I noted during the conference that in the USA alone there are something in the order of 210+ BILLION pain relief scripts per annum which would fit MoxDuo IR product. They are initially looking at gaining 5% market share as a realistic target. This equates to more than 10 BILLION scripts. This is massive.

    As stated, further deals to be done in Europe, Australian and Canada.
 
watchlist Created with Sketch. Add QRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.